BFAM vs NBIX · P/E 19, rev $1.49B vs P/E 45, rev $1.77B
Bright Horizons Family Solutions Inc (BFAM) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Bright Horizons Family Solutions Inc (BFAM) is a personal services company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported BFAM revenue for 2026-06-30 was $1.49B. Net income was $74.7M. BFAM currently screens at market cap $3.29B and trailing P/E 18.8.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
BFAM currently screens at market cap $3.29B and trailing P/E 18.8. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the BFAM and NBIX stock pages for the full models.
Not investment advice.